Evidence map›Paper›PMID 36674518›Full record

ReviewInternational journal of molecular sciences2023

Biofilms in Chronic Wound Infections: Innovative Antimicrobial Approaches Using the In Vitro Lubbock Chronic Wound Biofilm Model.

Firas Diban, Silvia Di Lodovico, Paola Di Fermo, Simonetta D'Ercole, Sara D'Arcangelo, Mara Di Giulio, Luigina Cellini

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Sustainable ZnO/ZnGels (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Biofilm-Responsive Nanoplatforms for Infected Wound Reconstruction.International journal of nanomedicine · 2026
    Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Firas DibanDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0003-1509-6087
Silvia Di LodovicoDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0001-9281-5028
Paola Di FermoDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.
Simonetta D'ErcoleDepartment of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0002-4797-4019
Sara D'ArcangeloDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.
Mara Di GiulioDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0002-8375-9404
Luigina CelliniDepartment of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0003-4068-9124
University of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds have harmful effects on both patients and healthcare systems. Wound chronicity is attributed to an impaired healing process due to several host and local factors that affect healing pathways. The resulting ulcers contain a wide variety of microorganisms that are mostly resistant to antimicrobials and possess the ability to form mono/poly-microbial biofilms. The search for new, effective and safe compounds to handle chronic wounds has come a long way throughout the history of medicine, which has included several studies and trials of conventional treatments. Treatments focus on fighting the microbial colonization that develops in the wound by multidrug resistant pathogens. The development of molecular medicine, especially in antibacterial agents, needs an in vitro model similar to the in vivo chronic wound environment to evaluate the efficacy of antimicrobial agents. The Lubbock chronic wound biofilm (LCWB) model is an in vitro model developed to mimic the pathogen colonization and the biofilm formation of a real chronic wound, and it is suitable to screen the antibacterial activity of innovative compounds. In this review, we focused on the characteristics of chronic wound biofilms and the contribution of the LCWB model both to the study of wound poly-microbial biofilms and as a model for novel treatment strategies.

Indexed as

Anti-Infective AgentsWound InfectionAnti-Bacterial AgentsBiofilmsHumansPersistent InfectionPseudomonas aeruginosaAnti-Bacterial AgentsAnti-Infective Agentschronic woundLubbock chronic wound biofilm modelPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID36674518
PMCPMC9862456
OpenAlexW4313576877

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.